Polygenic risk scores: a European cancer priority
Polygenic risk scores can improve prevention and early detection of cancer.
Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.
She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.
Polygenic risk scores can improve prevention and early detection of cancer.
Research group in Oslo Cancer Cluster Incubator develops new cancer treatment
Three Nordic start-ups pitched at the International Cancer Cluster Showcase 2023. This year’s International Cancer Cluster Showcase (ICCS) featured 20 emerging oncology companies that presented their recent innovations, partnering and investment opportunities on 5 June 2023 in Boston, as a satellite event to BIO International Convention. The companies were selected by innovation hubs in the […]
Investors wanted to learn about Norwegian cancer companies.
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.